da nk AGM saham kne cantik hihi

Laiiii

laii

solar related co jalan

25sen resistance

naik lebih 10sen jap lagi

Res 22c

Take a look EG fair price here

https://simplywall.st/stocks/my/consumer-durables/klse-eg/eg-industries-berhad-shares

Telcos may consider M&A to ramp up scale, innovation, says Roland Berger

Telcos may consider M&A to ramp up scale, innovation, says Roland Berger

By Bernama | 2020-06-06 00:55:56
KUALA LUMPUR (June 5): Telecommunication service providers with access to capital will likely explore tactical opportunities post COVID-19, including mergers and acquisitions (M&A) to rapidly ramp up scale and innovation, foresees a global strategy consulting firm.

Roland Berger Southeast Asia co-managing partner Damien Dujacquier said the value of sectors such as communications and technology relative to the overall market has risen as resilience becomes evident amidst the crisis.

“We at Roland Berger start to recognise a growing theme around acquiring capabilities with a significant role in the post-COVID world, namely video conferencing solutions, virtual concerts and virtualised networks.

Logic

Tgt 14sen

Tgt 27c

By Bernama | 2020-05-08 23:40:21
KUALA LUMPUR (May 8): The COVID-19 pandemic will accelerate the move by companies particularly micro, small and medium-sized enterprises (MSMEs) towards the digital economy, said Alibaba Group.

http://bbqmalaysia.com

Done by Inix

High 30.5c

28.5c now

Laiiii

Biohldg 11.5sen

PE 11x
Net asset 19c
www.bioa.com.my

The Group expects the operating environment to remain challenging for both local and
overseas markets, in line with the prevailing cautious consumer spending, with uncertainties
arising from geopolitical tensions and coronavirus (“Covid-19”) outbreak. Against this
backdrop, the Group remains focused on strengthening the manufacturing of health
supplement products and retail pharmacy businesses while keeping cost in check.
For the domestic manufacturing business, the Group continues its efforts to secure new
Original Design Manufacturing (“ODM”) customers, while servicing our existing ones. We
expect the local ODM market to pick up going into FY2020.
Nonetheless, in the short term, concerns still remain following the unexpected Covid-19
outbreak. We have since experienced a surge in sales at our Constant pharmacy outlets for
hygiene-related items such as surgical masks and sanitizers, as well as our immunity-related
health supplement products. However, the overall impact of the situation can only be
assessed in the coming months. We are monitoring the outbreak closely and are taking
proactive steps to manage any situation arising from it.
As for our export business, in view of the current developments and Covid-19 outbreak, the
Group expects export sales to pick up in the second half of the year. Specifically in China, the
Group continues to work closely with distributors and partners there. Progress in Indonesia,
on the other hand, had been muted in FY2019 due to slower-than-expected regulatory
approvals for the health supplement products. The Group foresees revenue from Indonesia
to pick up once more approvals are secured in FY2020.

Net asset 19c